CNO (CNO) CMO Tarasi exercises options, sells 9,058 shares under Rule 10b5-1 plan

Rhea-AI Filing Summary

CNO Financial Group Chief Marketing Officer Rocco F. Tarasi III exercised stock options and sold shares in CNO Financial Group, Inc. common stock. He exercised 5,750 options at $21.06 per share and on the same date sold 5,750 shares at $50.00 per share in an open-market sale. He also sold 3,308 shares at $49.00 per share on a prior trading day. These sales were made under a Rule 10b5-1 trading plan adopted on February 24, 2026. After the transactions, he directly owns 79,191 common shares, showing he continues to hold a substantial equity stake.

Insights

Equity compensation and insider trading analyst

Tarasi’s Form 4 shows an option exercise paired with planned share sales.

The transactions combine an option exercise with open-market sales. Tarasi exercised 5,750 employee stock options at $21.06 per share and sold 5,750 shares at $50.00, plus 3,308 shares at $49.00, realizing value from long-vested awards.

The filing notes that the sales occurred under a Rule 10b5-1 trading plan adopted on February 24, 2026, indicating they were pre-arranged rather than opportunistic. After the transactions, Tarasi still holds 79,191 common shares directly, and this option grant is fully exercised, with no remaining derivative position from it.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Tarasi Rocco F. III

Role Chief Marketing Officer

Sold 9,058 shs ($450K)

Approx. gross sale proceeds $450K

Approx. exercise cost $121K

Type	Security	Shares	Price	Value
Exercise	Employee Stock Option (Right to Buy)	5,750	$0.00	$0.00
Exercise	Common Stock	5,750	$21.06	$121K
Sale	Common Stock	5,750	$50.00	$288K
Sale	Common Stock	3,308	$49.00	$162K

Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 79,191 shares (Direct)

Footnotes (2)

1. F1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026.
2. F2. One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020.

Key Figures

Shares sold at $50.00: 5,750 shares Shares sold at $49.00: 3,308 shares Options exercised: 5,750 shares at $21.06/share +4 more

7 metrics

Shares sold at $50.00 5,750 shares Common stock open-market sale at $50.00 per share

Shares sold at $49.00 3,308 shares Common stock open-market sale at $49.00 per share

Options exercised 5,750 shares at $21.06/share Employee stock option exercise price for common stock

Net shares sold 9,058 shares Net-sell direction from transaction summary

Shares owned after 79,191 shares Direct common stock holdings following transactions

Rule 10b5-1 plan adoption date February 24, 2026 Plan governing the share sales

Option expiration date February 23, 2027 Employee stock option grant expiration before exercise

Key Terms

Rule 10b5-1 trading plan, Employee Stock Option (Right to Buy), open-market sale, derivative exercise/conversion

4 terms

Rule 10b5-1 trading plan regulatory

"Shares sold pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Employee Stock Option (Right to Buy) financial

"security_title: Employee Stock Option (Right to Buy)"

open-market sale financial

"transaction_action: open-market sale"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

derivative exercise/conversion financial

"transaction_action: derivative exercise/conversion"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/11/2026 - 04:10 PM Accepted by SEC EDGAR 06/11/2026 - 04:09 PM Learn about SEC filing dates

FAQ

What did CNO (CNO) executive Rocco F. Tarasi III report in this Form 4?

Rocco F. Tarasi III reported exercising employee stock options and selling CNO common shares. He exercised 5,750 options at $21.06 per share and sold 9,058 shares in total at prices of $49.00 and $50.00 per share.

How many CNO shares did Rocco F. Tarasi III sell and at what prices?

He sold 9,058 CNO common shares in open-market transactions. This included 3,308 shares at $49.00 per share and 5,750 shares at $50.00 per share, as disclosed in the Form 4 insider trading report.

What stock options did Rocco F. Tarasi III exercise in CNO Financial Group?

Tarasi exercised 5,750 employee stock options with a conversion or exercise price of $21.06 per share. These options related to CNO common stock and were fully exercised, leaving zero options from this grant outstanding after the transaction.

How many CNO shares does Rocco F. Tarasi III own after these transactions?

Following the reported trades, Tarasi directly owns 79,191 shares of CNO common stock. This figure reflects his remaining equity stake after exercising 5,750 options and selling a total of 9,058 shares in open-market transactions.

Were Rocco F. Tarasi III’s CNO share sales made under a Rule 10b5-1 plan?

Yes. The filing states the shares were sold pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026. Such plans pre-schedule trades, indicating these sales were arranged in advance rather than timed discretionarily.

What is the net share effect of Rocco F. Tarasi III’s CNO transactions?

The transaction summary shows a net sale of 9,058 shares. He exercised 5,750 options to acquire shares but sold more shares than he acquired, leading to a net-sell direction while still retaining 79,191 CNO shares afterward.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tarasi Rocco F. III

(Last) (First) (Middle)

C/O CNO FINANCIAL GROUP, INC.

11299 ILLINOIS STREET, SUITE 200

(Street)

CARMEL INDIANA 46032

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CNO Financial Group, Inc. [ CNO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		S		3,308(1)	D	$49	79,191	D
Common Stock	06/11/2026		M		5,750	A	$21.06	84,941	D
Common Stock	06/11/2026		S		5,750(1)	D	$50	79,191	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$21.06	06/11/2026		M			5,750	(2)	02/23/2027	Common Stock	5,750	$0	0	D

Explanation of Responses:

1. Shares sold pursuant to a Rule 10b5-1 trading plan adopted on February 24, 2026.

2. One-half of the stock options vested and became exercisable on February 23, 2019, and one-half vested and became exercisable on February 23, 2020.

Remarks:

	Heidi M. Krings, Attorney-in-Fact	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)